<DOC>
	<DOCNO>NCT00529412</DOCNO>
	<brief_summary>To assess whether use Seprafilm reduces rate small bowel obstruction patient underwent surgery gastric cancer .</brief_summary>
	<brief_title>Bioresorbable Membrane Reduce Postoperative Small Bowel Obstruction</brief_title>
	<detailed_description>Patients gastric cancer schedule undergo gastrectomy randomly assign sodium hyaluronate-based bioresorbable membrane ( Seprafilm ) group control group . Before close abdominal incision , two sheet Seprafilm membrane apply surface small intestine middle abdominal wound Seprafilm group . The primary end point incidence bowel obstruction . Secondary end point intraoperative postoperative morbidity mortality .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Intestinal Obstruction</mesh_term>
	<criteria>Clinical diagnosis gastric cancer Operable Withdrew consent Pregnant Ascites Distant metastasis Liver dysfunction ( serum total bilirubin &gt; 2.0 mg/dL ) Renal failure ( serum creatinine &gt; 1.5 mg/dL ) A past history small bowel obstruction .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>June 2007</verification_date>
</DOC>